Chemed (Chemed) Bad Debt Percentage of Revenue % : 1.00% (As of Dec. 2023)

View and export this data going back to 1982. Start your Free Trial

What is Chemed Bad Debt Percentage of Revenue %?

Bad Debt Percentage of Revenue % can be used to estimate the company’s bad debt value. If the company’s bad debt percentage is from historical data, the metric can be used as an indicator of a company's receivable management ability. Under the requirements of transparency and accuracy, lower Bad Debt Percentage of Revenue is better.

Chemed's Bad Debt Percentage of Revenue % for the quarter that ended in Dec. 2023 was 1.00% , which is lower than 1.30% for the pervious quarter ended in Sep. 2023.

Chemed's Bad Debt Percentage of Revenue % for the annual that ended in Dec. 2023 was 1.10% , which is higher than 1.00% for the pervious year ended in Dec. 2022.

The historical rank and industry rank for Chemed's Bad Debt Percentage of Revenue % or its related term are showing as below:

CHE's Bad Debt Percentage of Revenue % is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median:
* Ranked among companies with meaningful Bad Debt Percentage of Revenue % only.

Chemed Bad Debt Percentage of Revenue % Historical Data

The historical data trend for Chemed's Bad Debt Percentage of Revenue % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemed Bad Debt Percentage of Revenue % Chart

Chemed Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Bad Debt Percentage of Revenue %

Get a 7-Day Free Trial

ChemedQuarterly Data

Trend

Mar19

Jun19

Sep19

Dec19

Mar20

Jun20

Sep20

Dec20

Mar21

Jun21

Sep21

Dec21

Mar22

Jun22

Sep22

Dec22

Mar23

Jun23

Sep23

Dec23

Bad Debt Percentage of Revenue %

Get a 7-Day Free Trial

Competitive Comparison of Chemed's Bad Debt Percentage of Revenue %

For the Medical Care Facilities subindustry, Chemed's Bad Debt Percentage of Revenue %, along with its competitors' market caps and Bad Debt Percentage of Revenue % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chemed (NYSE:CHE) Bad Debt Percentage of Revenue % Calculation

Companies usually use Bad Debt Percentage of Revenue % to estimate their bad debt. The initial estimates of a company's bad debt allowance is typically based upon past performance. The formula is:

Bad Debt Percentage of Revenue %

( Uncollectible sales

Revenue )

100 %

Chemed (NYSE:CHE) Bad Debt Percentage of Revenue % Explanation

A bad debt expense is recognized when a receivable is no longer collectible because a customer is unable to fulfill their obligation to pay an outstanding debt due to bankruptcy or other financial problems.

The analysis of bad debt should be combined with the allowance and adjustment the company made of the fiscal year. If the company’s Bad Debt Percentage of Revenue % kept increasing, the company’s profitability should be questioned. However, abnormal low ratios are also worth attention because it may be a sign of fiscal report manipulation.

Chemed Bad Debt Percentage of Revenue % Related Terms

Thank you for viewing the detailed overview of Chemed's Bad Debt Percentage of Revenue % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chemed (Chemed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chemed Corp (NYSE:CHE) » Definitions » Bad Debt Percentage of Revenue %

Comparable Companies

Traded in Other Exchanges

CXM:Germany

Address

255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726

Website

https://www.chemed.com

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.

Executives

Kevin J Mcnamara	director, officer: president & ceo	2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
Spencer S Lee	officer: vice president	2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
David Patrick Williams	officer: Vice President & CFO
Nicholas Michael Westfall	officer: Executive Vice President	8035 PEREGRINE LANE, CINCINNATI OH 45243
Patrick P Grace	director	1100 PARK AVE, APT 15C, NEW YORK NY 10128
Eileen P Mccarthy	director	3515 78TH STREET, #2, JACKSON HEIGHTS NY 11372
Michael D Witzeman	officer: vice president and controller	255 E 5TH STREET, SUITE 2600, CINCINNATI OH 45202
Mount John Meredith Jr.	director	2906 MABRY ROAD NE, ATLANTA GA 30319
Donald E Saunders	director	306 MIANI TRAIL, OXFORD OH 45056
Christopher J Heaney	director	101 S. FORT LAUDERDALE BEACH BLVD., APARTMENT 1602, FORT LAUDERDALE FL 33316
Ron Delyons	director	2692 MADISON ROAD, SUITE N1-313, CINCINNATI OH 45208
Naomi C Dallob	officer: VP and Chief Legal Officer	255 EAST FIFTH STREET, SUITE 2600, CINCINNATI OH 45202
Thomas C Hutton	director, officer: vice president	ONE ROCKEFELLER PLAZA, STE 1510, NEW YORK NY 10020
Walsh George J Iii	director	ONE CHASE MANHATTAN PLAZA, NEW YORK NY 10005
Andrea R Lindell	director